New bioterrorism rules 'strike balance,' says FMI

McTaggart, Jenny
November 2003
Progressive Grocer;11/1/2003, Vol. 82 Issue 16, p6
Trade Publication
Provides information on interim bioterrorism rules issued by the U.S. Food and Drug Administration in 2003. Comments from Tim Hammonds, president and CEO of the Food Marketing Institute on the rules; Details of the shorter-prior notice requirements under the rules.


Related Articles

  • FDA Drops Lot Code Tracking. Garry, Michael // SN: Supermarket News;12/13/2004, Vol. 52 Issue 50, p6 

    Reports on the decision of the U.S. Food and Drug Administration to cancel tracking manufacturer lot codes in 2004 under the Bioterrorism Act of 2002. Statement issued by Tim Hammonds, CEO of the Food Marketing Institute, on lot code tracking; Terms and conditions of the rules under the...

  • FDA is listening to importers. Fuchs, Carol // Journal of Commerce (1542-3867);10/27/2003, Vol. 4 Issue 43, p38 

    Focuses on the actions taken by the U.S. Department of Food and Drugs on issues regarding the implementation of final interim rules on the Bioterrorism Act of 2002. Obligation of importers under the final interim rule; Information on accomplishing the registration provision; Discussion on issue...

  • Adjusting FDA policies to address bioterrorist threat. Fox, Jeffrey L. // Nature Biotechnology;Apr99, Vol. 17 Issue 4, p323 

    Focuses on challenges facing officials at the U.S. Food and Drug Administration (FDA) in making policy changes to combat the threat of bioterrorism in the country. Challenges facing FDA in evaluating vaccines to protect against bioterrorist-inflicted diseases; Changes in policy being...

  • Bioterrorism Page Opens Door to Information. Henkel, John // FDA Consumer;Jan/Feb2002, Vol. 36 Issue 1, p34 

    Presents information on a Web site created by the United States Food and Drug Administration that links to background about bioterrorism and offers a quick study on the subject.

  • Ban the Bromate.  // Nutrition Action Health Letter;Oct99, Vol. 26 Issue 8, p2 

    Focuses on the efforts of the United States Food and Drug Administration to ban bromate in baked goods. Adverse effects of potassium bromate; Brands that still use potassium bromate.

  • Bill seeks to bring FDA's blurry lines into focus. Wechsler, Jill // Managed Healthcare;Dec97, Vol. 7 Issue 12, p22 

    Focuses on the legislation that clarifies the United States Food and Drug Administration regulations. Allowing of pharmaceutical companies to disseminate competent healthcare economic information to sophisticated purchasers; Allowing of drugmakers to distribute peer-reviewed journal articles...

  • New molecular entities.  // Formulary;Sep97, Vol. 32 Issue 9, p881 

    Presents several drugs approved by the US Food and Drug Administration. Sodium capsules for the management of pain; Tablets for the treatment of advanced breast cancer; Dopamine agonist for the treatment of Parkinson's disease.

  • FDA issues reprint guidelines.  // Dermatology Times;Jan1996, Vol. 17 Issue 1, p68 

    Reports that the Food and Drug Administration will be issuing guidelines, permitting distribution of journal reprints studies, that support an approved indication, but make reference to unapproved uses. What companies will be allowed to distribute; Guidelines concerning IND submission.

  • FDA Safety Page. Holquist, Carol // Patient Care;1/15/2002, Vol. 36 Issue 1, p54 

    Focuses on the drug name review process created by the U.S. Food and Drug Administration in January 2002. Handwriting and verbal analyses; Computer assisted analysis; Evaluation of risks.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics